MicroPort MedBot Successfully Hosts RS3 Journal Club in Singapore with idsMED, Gaining Recognition from Asia-Pacific’s Premier Academic Platform for Its 'Made-in-China' Surgical Robot
Edge Medical
Developer of Robot-Assisted Minimally Invasive Surgical Systems
IDS Medical Systems
Integrated Solutions Provider for Medical Devices, Supplies, and Services
Recently, Edge Medical® successfully held the Robotic Surgery Society of Singapore (RS3) Journal Club Roundtable Meeting in collaboration with its local Singaporean partner, IDS Medical Systems. The event brought together top robotic surgery experts from Singapore to discuss the latest advancements in minimally invasive surgical techniques, with a particular focus on showcasing Edge Medical.®The Innovative Value and Global Achievements of the MSP2000 Multi-Port and Single-Port Integrated Surgical Robot Super System.
Authoritative Academic Platform Sharing
Joint Discussion on Cross-Specialty Clinical Value
Singapore is a hub for advanced medical care in the Asia-Pacific region, with its expert opinions holding significant influence across Southeast Asia and the broader Asia-Pacific. The Robotic Surgery Society of Singapore (RS3) consists of individual members with specialized interests in robotic technology research, including clinicians, scientists, and healthcare professionals. The society is committed to advancing the field of robotic surgery by enhancing surgical quality and patient outcomes through collaboration, advocacy, research, standard-setting, and training, while also promoting interdisciplinary exchange. Its occasional seminars have become one of the key platforms for interdisciplinary academic exchange on surgical robotics in the Asia-Pacific region.
Dr. Joseph Ng Soon Yau, Founding Chairman of RS3 Journal Club and obstetrics and gynecology specialist at the National University Hospital of Singapore, emphasized in his opening remarks that surgical robots are playing an increasingly critical role in cross-disciplinary clinical practices – from gynecology, urology to general surgery, robot-assisted surgeries are reshaping the boundaries of traditional operations, offering patients more precise and minimally invasive treatment options.
Clinical Evidence from China's Top Hospitals
Internationally First-Class Level, More Cost-Effective
Professor Hu Hao from the Department of Urology at Peking University People's Hospital, one of China's top tertiary hospitals, shared in detail the clinical experience of using the Edge Medical surgical robot for complex urological reconstructive surgeries.
Professor Hu's presentation covered three core areas: robotic surgery for urological tumors, management of ureteral stricture cases ranging from mild to severe, and reconstructive flap techniques using 7 degrees-of-freedom instruments for precision operations.
Professor Hu Hao commented, "In terms of 3D high-definition visual accuracy and intuitive control, Edge Medical's robot has reached an internationally first-class level, with superior cost-effectiveness."
From Leading in China to Global Layout
One Platform, Multiple Values
As the first company in China and the second globally to simultaneously obtain regulatory approval for multi-port, single-port endoscopic surgical robots and natural orifice surgical robots, Edge Medical is leading the high-quality development of advanced surgical robots in China through platform-based innovation. The APAC Sales Director of Edge Medical comprehensively shared the company's development history, market position, and product technology advantages with the attending experts, focusing on introducing the world's first integrated single-port and multi-port surgical robot super system, MSP2000, developed by Edge Medical.
This platform achieves a systematic integration of multi-port and single-port technologies, not only fully leveraging the extensive application scope and diverse surgical options of multi-port robots but also incorporating the ultra-minimally invasive nature, aesthetically pleasing incisions, and rapid recovery associated with single-port robots. Additionally, the platform has robust expansion capabilities, enabling it to be equipped with Edge Medical's remote surgery system, allowing expert surgeries to transcend geographical limitations and elevating the potential applications of surgical robots to an entirely new level. This creates a triple-win scenario: For patients, personalized surgical plans result in minimal trauma and faster recovery; for doctors, one system fulfills the needs of multi-port surgeries, cutting-edge single-port procedures, and remote research; for hospitals, it realizes the strategic value of "one platform, multiple functions" with more efficient investment.
Multiple experts expressed during exchanges that the disruptive technological breakthroughs and innovative product ecosystem of the Edge Medical robot comprehensively cover diverse clinical scenarios, showcasing the team's deep understanding of clinical needs. It redefines the boundaries of minimally invasive surgery and serves as an ideal platform for advancing surgical technology toward both widespread adoption and cutting-edge sophistication. The robot has also gained increasing attention and recognition in the Asia-Pacific market.
The successful hosting of this RS3 Journal Club further solidifies Edge Medical® as a key player in the global robotic surgery industry, while opening up broader prospects for clinical collaboration in the Asia-Pacific region.
Edge Medical® will continue to deepen its presence in the Asia-Pacific market, promoting more cross-regional academic exchanges and clinical research collaborations, allowing surgical robots made in China to benefit more doctors and patients.
